Clinical Trials Browser

Phase 2 × NIH × Metastatic Lung Non-Squamous Non-Small Cell Carcinoma × Clear all

NCT03468985 2023-10-17

Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer

Phase 2 Completed

3 enrolled 10 charts

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma